Guardian Pharmacy Services price to sales ratio GRDN
Market value divided by revenue over the last twelve months, since 2025.
- Today, Nov 2, 2026
- 1.7×
- Peer median
- 1.9×
Guardian Pharmacy Services' price to sales ratio is 1.7× as of Nov 2, 2026.
The median for 10 healthcare stocks of a similar size is 1.9×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.7× | 1.2× | 1.9× |
| 2025 | 1.4× | 1.1× | 1.4× |
Against its peers
Companies in Healthcare nearest Guardian Pharmacy Services' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| GRDNGuardian Pharmacy Services | 1.7× |
| ADMAAdma Biologics | 4.8× |
| MDPediatrix Medical | 1.2× |
| PRVAPrivia Health | 1.2× |
| PBHPrestige Consumer Healthcare | 2.1× |
| ADUSAddus HomeCare | 1.6× |
| TMDXTransMedics | 3.5× |
| NRIXNurix Therapeutics | 4.0× |
| PGNYProgyny | 1.7× |
| AVAHAveanna Healthcare | 1.1× |
| HRMYHarmony Biosciences | 2.3× |
| Peer median | 1.9× |
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Guardian Pharmacy Services
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.